ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 3,995 | 3,995 | 3,935 | 3,935 | -45 | -1.1% | 221,000 |
2021/03/22 | 3,945 | 4,005 | 3,930 | 3,980 | +50 | +1.3% | 221,600 |
2021/03/19 | 3,905 | 3,950 | 3,885 | 3,930 | -15 | -0.4% | 280,000 |
2021/03/18 | 3,935 | 4,000 | 3,910 | 3,945 | +10 | +0.3% | 251,900 |
2021/03/17 | 3,800 | 3,945 | 3,775 | 3,935 | +205 | +5.5% | 328,000 |
2021/03/16 | 3,700 | 3,730 | 3,675 | 3,730 | +10 | +0.3% | 151,700 |
2021/03/15 | 3,715 | 3,735 | 3,680 | 3,720 | +15 | +0.4% | 125,200 |
2021/03/12 | 3,685 | 3,715 | 3,635 | 3,705 | -20 | -0.5% | 193,700 |
2021/03/11 | 3,600 | 3,730 | 3,600 | 3,725 | +125 | +3.5% | 260,500 |
2021/03/10 | 3,530 | 3,625 | 3,525 | 3,600 | +90 | +2.6% | 175,700 |
2021/03/09 | 3,510 | 3,520 | 3,470 | 3,510 | +45 | +1.3% | 117,500 |
2021/03/08 | 3,500 | 3,515 | 3,435 | 3,465 | -15 | -0.4% | 121,400 |
2021/03/05 | 3,430 | 3,480 | 3,410 | 3,480 | +50 | +1.5% | 162,200 |
2021/03/04 | 3,420 | 3,430 | 3,390 | 3,430 | +10 | +0.3% | 96,100 |
2021/03/03 | 3,420 | 3,445 | 3,365 | 3,420 | +5 | +0.1% | 160,000 |
2021/03/02 | 3,405 | 3,415 | 3,365 | 3,415 | +60 | +1.8% | 147,800 |
2021/03/01 | 3,400 | 3,405 | 3,330 | 3,355 | +10 | +0.3% | 94,400 |
2021/02/26 | 3,395 | 3,415 | 3,340 | 3,345 | -50 | -1.5% | 184,300 |
2021/02/25 | 3,435 | 3,440 | 3,375 | 3,395 | +15 | +0.4% | 130,100 |
2021/02/24 | 3,410 | 3,420 | 3,370 | 3,380 | -55 | -1.6% | 119,700 |
2021/02/22 | 3,475 | 3,480 | 3,420 | 3,435 | +30 | +0.9% | 114,200 |
2021/02/19 | 3,470 | 3,490 | 3,390 | 3,405 | -115 | -3.3% | 133,500 |
2021/02/18 | 3,460 | 3,530 | 3,430 | 3,520 | +95 | +2.8% | 165,800 |
2021/02/17 | 3,500 | 3,505 | 3,420 | 3,425 | -100 | -2.8% | 147,300 |
2021/02/16 | 3,440 | 3,540 | 3,420 | 3,525 | +70 | +2% | 170,900 |
2021/02/15 | 3,420 | 3,475 | 3,395 | 3,455 | +55 | +1.6% | 169,800 |
2021/02/12 | 3,425 | 3,430 | 3,385 | 3,400 | +30 | +0.9% | 217,100 |
2021/02/10 | 3,365 | 3,395 | 3,335 | 3,370 | -30 | -0.9% | 215,600 |
2021/02/09 | 3,505 | 3,510 | 3,365 | 3,400 | -115 | -3.3% | 309,900 |
2021/02/08 | 3,560 | 3,560 | 3,345 | 3,515 | -50 | -1.4% | 432,900 |
2021/02/05 | 3,500 | 3,595 | 3,475 | 3,565 | +100 | +2.9% | 272,800 |
2021/02/04 | 3,470 | 3,500 | 3,460 | 3,465 | -5 | -0.1% | 89,500 |
2021/02/03 | 3,420 | 3,485 | 3,420 | 3,470 | +55 | +1.6% | 93,600 |
2021/02/02 | 3,390 | 3,415 | 3,370 | 3,415 | +5 | +0.1% | 115,100 |
2021/02/01 | 3,395 | 3,425 | 3,395 | 3,410 | +5 | +0.1% | 135,100 |
2021/01/29 | 3,420 | 3,490 | 3,400 | 3,405 | -50 | -1.4% | 179,600 |
2021/01/28 | 3,410 | 3,470 | 3,395 | 3,455 | +35 | +1% | 561,800 |
2021/01/27 | 3,405 | 3,465 | 3,405 | 3,420 | +50 | +1.5% | 153,400 |
2021/01/26 | 3,390 | 3,430 | 3,370 | 3,370 | -25 | -0.7% | 144,100 |
2021/01/25 | 3,375 | 3,410 | 3,360 | 3,395 | +50 | +1.5% | 174,000 |
2021/01/22 | 3,390 | 3,390 | 3,330 | 3,345 | -115 | -3.3% | 141,700 |
2021/01/21 | 3,435 | 3,480 | 3,420 | 3,460 | +55 | +1.6% | 157,800 |
2021/01/20 | 3,360 | 3,410 | 3,340 | 3,405 | +60 | +1.8% | 123,600 |
2021/01/19 | 3,355 | 3,360 | 3,315 | 3,345 | -10 | -0.3% | 120,800 |
2021/01/18 | 3,475 | 3,505 | 3,345 | 3,355 | -90 | -2.6% | 156,300 |
2021/01/15 | 3,455 | 3,480 | 3,435 | 3,445 | +40 | +1.2% | 204,200 |
2021/01/14 | 3,355 | 3,415 | 3,335 | 3,405 | +30 | +0.9% | 210,400 |
2021/01/13 | 3,330 | 3,380 | 3,330 | 3,375 | +30 | +0.9% | 191,800 |
2021/01/12 | 3,285 | 3,355 | 3,275 | 3,345 | +45 | +1.4% | 186,000 |
2021/01/08 | 3,235 | 3,305 | 3,230 | 3,300 | +80 | +2.5% | 176,400 |
901~
950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 273,800円 | +56.7% | +357.2% | 0.00% | 25.35倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム